These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The challenge of differentiating asthma from chronic obstructive pulmonary disease. Hanania NA Manag Care; 2005 Jul; 14(7 Suppl Obstructie Lung):9-15; discussion 24-6. PubMed ID: 18564559 [No Abstract] [Full Text] [Related]
25. Prescription drugs uses and effects. Bronchodilators: adrenoreceptor agonists. Jordan S Nurs Stand; 2004 Apr 21-27; 18(32):2p.. PubMed ID: 15132040 [No Abstract] [Full Text] [Related]
26. Sharpening the clinical diagnostic borders of chronic obstructive pulmonary disease. Jenkins C Intern Med J; 2003 Dec; 33(12):551-3. PubMed ID: 14656225 [No Abstract] [Full Text] [Related]
27. [Asthma in the elderly]. Lindner K; Panaszek B; Machaj Z Pol Arch Med Wewn; 2007 Aug; 117(8):350-4. PubMed ID: 18018382 [TBL] [Abstract][Full Text] [Related]
28. Management of COPD in general practice. Henderson J; Harrison C; Miller G Aust Fam Physician; 2012 Nov; 41(11):841. PubMed ID: 23145412 [TBL] [Abstract][Full Text] [Related]
29. [ICS not indicated in the early stage]. Einecke D MMW Fortschr Med; 2015 Dec; 157(21-22):85. PubMed ID: 26960883 [No Abstract] [Full Text] [Related]
30. [Does phenotyping asthma help to improve differential treatment?]. Taube C; Buhl R Dtsch Med Wochenschr; 2010 Mar; 135(10):468-73. PubMed ID: 20198546 [TBL] [Abstract][Full Text] [Related]
31. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma. Buhl R; Farmer SG Proc Am Thorac Soc; 2004; 1(2):136-42. PubMed ID: 16113426 [TBL] [Abstract][Full Text] [Related]
33. [Recommendations for nebulizer therapy]. Diot P; Zarka V; Lemarié E Rev Mal Respir; 2002 Feb; 19(1):87-9. PubMed ID: 17546818 [No Abstract] [Full Text] [Related]
34. Rescue! Therapy and the paradox of the Barcalounger. Rennard SI; Calverley P Eur Respir J; 2003 Jun; 21(6):916-7. PubMed ID: 12797481 [No Abstract] [Full Text] [Related]
35. Personalised Medicine for Asthma and Chronic Obstructive Pulmonary Disease. Heaney LG; McGarvey LP Respiration; 2017; 93(3):153-161. PubMed ID: 28110335 [TBL] [Abstract][Full Text] [Related]
36. [Introduction to asthma and chronic obstructive pulmonary disease pharmacoeconomics]. Jahnz-Rózyk K Pol Merkur Lekarski; 2004 May; 16 Suppl 1():5-6, 8. PubMed ID: 15524004 [TBL] [Abstract][Full Text] [Related]
37. Targeting immune pathways for therapy in asthma and chronic obstructive pulmonary disease. Brusselle G; Bracke K Ann Am Thorac Soc; 2014 Dec; 11 Suppl 5():S322-8. PubMed ID: 25525740 [TBL] [Abstract][Full Text] [Related]
38. Disease Burden of Patients with Asthma/COPD Overlap in a US Claims Database: Impact of ICD-9 Coding-based Definitions. Wurst KE; St Laurent S; Hinds D; Davis KJ COPD; 2017 Apr; 14(2):200-209. PubMed ID: 28103123 [TBL] [Abstract][Full Text] [Related]
39. Application of management guidelines to the assessment of new medicines: driving us forward or holding us back? Calverley PM; Rennard SI Eur Respir J; 2004 Jun; 23(6):793-4. PubMed ID: 15218985 [No Abstract] [Full Text] [Related]
40. The asthma-chronic obstructive pulmonary disease overlap syndrome and its challenge for the allergist-immunologist. Bellanti JA; Settipane RA Allergy Asthma Proc; 2015; 36(1):1-3. PubMed ID: 25562548 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]